1. Home
  2. BIRK vs EXAS Comparison

BIRK vs EXAS Comparison

Compare BIRK & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIRK
  • EXAS
  • Stock Information
  • Founded
  • BIRK 1774
  • EXAS 1995
  • Country
  • BIRK United Kingdom
  • EXAS United States
  • Employees
  • BIRK N/A
  • EXAS N/A
  • Industry
  • BIRK
  • EXAS Medical Specialities
  • Sector
  • BIRK
  • EXAS Health Care
  • Exchange
  • BIRK Nasdaq
  • EXAS Nasdaq
  • Market Cap
  • BIRK 10.1B
  • EXAS 10.5B
  • IPO Year
  • BIRK 2023
  • EXAS N/A
  • Fundamental
  • Price
  • BIRK $51.84
  • EXAS $49.26
  • Analyst Decision
  • BIRK Strong Buy
  • EXAS Strong Buy
  • Analyst Count
  • BIRK 15
  • EXAS 17
  • Target Price
  • BIRK $67.27
  • EXAS $72.31
  • AVG Volume (30 Days)
  • BIRK 1.7M
  • EXAS 1.9M
  • Earning Date
  • BIRK 02-20-2025
  • EXAS 02-19-2025
  • Dividend Yield
  • BIRK N/A
  • EXAS N/A
  • EPS Growth
  • BIRK 173.97
  • EXAS N/A
  • EPS
  • BIRK 1.20
  • EXAS N/A
  • Revenue
  • BIRK $1,929,273,217.00
  • EXAS $2,758,867,000.00
  • Revenue This Year
  • BIRK $20.13
  • EXAS $12.09
  • Revenue Next Year
  • BIRK $17.07
  • EXAS $11.24
  • P/E Ratio
  • BIRK $43.36
  • EXAS N/A
  • Revenue Growth
  • BIRK 20.51
  • EXAS 10.37
  • 52 Week Low
  • BIRK $41.00
  • EXAS $40.62
  • 52 Week High
  • BIRK $64.78
  • EXAS $79.62
  • Technical
  • Relative Strength Index (RSI)
  • BIRK 34.07
  • EXAS 33.51
  • Support Level
  • BIRK $50.68
  • EXAS $45.94
  • Resistance Level
  • BIRK $57.67
  • EXAS $51.75
  • Average True Range (ATR)
  • BIRK 2.09
  • EXAS 2.13
  • MACD
  • BIRK -0.56
  • EXAS -0.30
  • Stochastic Oscillator
  • BIRK 15.74
  • EXAS 32.20

About BIRK Birkenstock Holding plc

Birkenstock Holding PLC is a company that manufactures and sells footbed-based products, including sandals, closed-toe silhouettes, and other products, such as skincare and accessories, for everyday, leisure, and work. It sells its products through two main channels: business-to-business (B2B) which comprises sales made to established third-party store networks, and direct-to-consumer (DTC) which comprises sales made on globally owned online stores through the Birkenstock.com domain and sales made in Birkenstock retail stores. The company's reportable segments are based on its regional hubs and include: the Americas which is also its key revenue-generating segment; Europe; and Australia, Japan, India, China, and the United Arab Emirates (APMA).

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a precancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: